Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ALVO
ALVO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ALVO News
Alvotech Increases Share Capital by $125,000
4d ago
Yahoo Finance
Alvotech Under Investigation Following 34% Stock Drop After FDA CRL
6d ago
Globenewswire
Alvotech Faces Securities Claims Investigation
6d ago
PRnewswire
Alvotech Faces Securities Claims Investigation by Rosen Law Firm
Feb 05 2026
Globenewswire
Alvotech's AVT80 Biosimilar Study Achieves Success
Feb 05 2026
seekingalpha
Alvotech Reports Positive Results for AVT80 Study
Feb 05 2026
stocktwits
Alvotech Reports Positive Results for AVT80 Clinical Study
Feb 05 2026
Newsfilter
Alvotech Faces Securities Claims Investigation
Feb 03 2026
Globenewswire
Alvotech Enters Supply Agreements with Sandoz for Biosimilars
Feb 02 2026
NASDAQ.COM
Alvotech Enters Supply Agreements with Sandoz for Biosimilars
Feb 02 2026
Newsfilter
Alvotech Faces Securities Claims Investigation by Rosen Law Firm
Jan 30 2026
Globenewswire
Alvotech Settles Patent Disputes with Regeneron and Bayer
Jan 29 2026
seekingalpha
Alvotech Reaches Licensing Settlement with Regeneron and Bayer
Jan 29 2026
Newsfilter
Alvotech Reaches Licensing Settlement with Regeneron and Bayer on Eylea Biosimilar
Jan 29 2026
Yahoo Finance
Alvotech Faces Securities Claims Investigation by Rosen Law Firm
Jan 27 2026
Globenewswire
Alvotech (NASDAQ: ALVO) Faces Securities Claims After 34% Stock Drop Due to Misleading Information
Jan 21 2026
Globenewswire
Show More News
